London · Delayed Price · Currency is GBP · Price in GBX Mereo BioPharma Group Statistics
Total Valuation
AIM:MPH has a market cap or net worth of GBP 39.07 million. The enterprise value is 12.10 million.
| Market Cap | 39.07M |
| Enterprise Value | 12.10M |
Important Dates
The next estimated earnings date is Wednesday, August 12, 2026.
| Earnings Date | Aug 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +5.37% |
| Shares Change (QoQ) | +0.17% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 117.01M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 103.19 |
| PB Ratio | 1.52 |
| P/TBV Ratio | 1.53 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.45 |
| EV / Sales | 32.49 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.48
| Current Ratio | 6.48 |
| Quick Ratio | 6.12 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -381.17 |
Financial Efficiency
Return on equity (ROE) is -75.87% and return on invested capital (ROIC) is -47.71%.
| Return on Equity (ROE) | -75.87% |
| Return on Assets (ROA) | -41.55% |
| Return on Invested Capital (ROIC) | -47.71% |
| Return on Capital Employed (ROCE) | -105.15% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 9,709 |
| Profits Per Employee | -693,420 |
| Employee Count | 39 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -5.36% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -5.36% |
| 50-Day Moving Average | 33.69 |
| 200-Day Moving Average | 34.79 |
| Relative Strength Index (RSI) | 17.95 |
| Average Volume (20 Days) | 133,356 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, AIM:MPH had revenue of GBP 378,653 and -27.04 million in losses. Loss per share was -0.17.
| Revenue | 378,653 |
| Gross Profit | 277,931 |
| Operating Income | -27.42M |
| Pretax Income | -27.04M |
| Net Income | -27.04M |
| EBITDA | -26.94M |
| EBIT | -27.42M |
| Loss Per Share | -0.17 |
Balance Sheet
The company has 27.43 million in cash and n/a in debt, with a net cash position of 27.43 million.
| Cash & Cash Equivalents | 27.43M |
| Total Debt | n/a |
| Net Cash | 27.43M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 25.79M |
| Book Value Per Share | 0.16 |
| Working Capital | 25.64M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 472,909 |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 73.40% |
| Operating Margin | -7,242.19% |
| Pretax Margin | -7,141.99% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AIM:MPH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.37% |
| Shareholder Yield | -5.37% |
| Earnings Yield | -69.21% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |